tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Zelira Therapeutics Secures $1 Million ATM Funding for Growth

Story Highlights
Zelira Therapeutics Secures $1 Million ATM Funding for Growth

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Zelira Therapeutics ( (AU:ZLD) ) just unveiled an announcement.

Zelira Therapeutics has secured a $1 million At-the-Market (ATM) funding facility with Securities Vault Pty Ltd to support its clinical programs and growth strategy. This facility provides Zelira with flexible access to equity capital over the next 12 months, allowing the company to align capital needs with operational activities while maintaining control over the timing and terms of capital issuances. The ATM agreement enhances Zelira’s financial flexibility and positions the company to advance its strategic objectives without incurring significant dilution or complex financing mechanisms.

More about Zelira Therapeutics

Zelira Therapeutics Ltd is a global leader in the development and commercialization of clinically validated cannabinoid-based medicines. The company focuses on advancing key clinical programs and implementing growth strategies in the cannabinoid medicine industry.

YTD Price Performance: -22.34%

Average Trading Volume: 380

Technical Sentiment Signal: Buy

Current Market Cap: $3.43M

Find detailed analytics on ZLD stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1